Amyloidosis affects millions of people, as a cause of Alzheimer's disease or a complication
of dialysis, and also causes rare conditions. The many forms of the disorder have one …

Knowledge about the systemic amyloidoses has increased considerably during the last few
years. This group of diseases is characterized by great biochemical variability, including at …

The ability of normally soluble proteins to convert into amyloid fibrils is now recognized to be
a generic phenomenon. The overall cross-β architecture of the core elements of such …

▪ Abstract The amyloidoses are diseases in which abnormalities in the secondary structure
of precursor proteins result in decreased solubility under physiologic conditions, with …

The amyloidoses are a group of disorders in which soluble proteins aggregate and deposit
extracellularly in tissues as insoluble fibrils, causing progressive organ dysfunction. The …

The amyloidoses are diseases characterized by the extracellular accumulation of insoluble
protein fibrils. From the initial pathologic description by Virchow in the mid-19th century until …

The amyloidoses are a group of protein misfolding diseases in which the precursor protein
undergoes a conformational change that triggers the formation of amyloid fibrils in different …

Amyloidosis is a rare group of diseases characterized by deposition of amyloid fibrils in soft
tissues. More than 28 types of amyloid have been identified. They all share common …

Cerebral amyloid diseases are part of a complex group of chronic and progressive entities
bracketed together under the common denomination of protein folding disorders and …

The amyloidoses constitute a large group of diseases caused by an alteration in the
conformation and metabolism of several globular proteins which, under particular …